scholarly journals Benchmarking occupational exoskeletons: An evidence mapping systematic review

2022 ◽  
Vol 98 ◽  
pp. 103582
Author(s):  
Sander De Bock ◽  
Jo Ghillebert ◽  
Renée Govaerts ◽  
Bruno Tassignon ◽  
Carlos Rodriguez-Guerrero ◽  
...  
2020 ◽  
Vol 49 ◽  
pp. 101231
Author(s):  
Aimee L. Ward ◽  
Andrew N. Reynolds ◽  
Sarahmarie Kuroko ◽  
Louise J. Fangupo ◽  
Barbara C. Galland ◽  
...  

2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Chris Bonell ◽  
Angela Harden ◽  
Helene Wells ◽  
Farah Jamal ◽  
Adam Fletcher ◽  
...  

BMJ Open ◽  
2018 ◽  
Vol 8 (4) ◽  
pp. e017249 ◽  
Author(s):  
Jong-chan Lee ◽  
Soyeon Ahn ◽  
In Kuk Cho ◽  
Jongchan Lee ◽  
Jaihwan Kim ◽  
...  

2021 ◽  
Vol 12 (2) ◽  
pp. 139
Author(s):  
Morankar Rahul ◽  
Nitesh Tewari ◽  
Vijay Mathur ◽  
Shubhi Goel ◽  
Gunjar Jain

2017 ◽  
Vol 35 (4_suppl) ◽  
pp. 448-448
Author(s):  
Jong-Chan Lee ◽  
Jin-Hyeok Hwang ◽  
Jaihwan Kim ◽  
Hyoung Woo Kim ◽  
Jongchan Lee

448 Background: Although almost patients with surgically resected pancreatic cancer (PC) experience recurrence, the optimal treatment option of recurrent PC is still unclear. Numerous studies have been reported about this issue, but all the scattered evidences are too small and heterogeneous to reach a conclusion. The aim of this systematic review is to perform ‘evidence mapping’ and subgroup meta-analysis. Methods: In regards to local recurrence and metastatic recurrence respectively, four treatment options including re-operation (ReOP), chemotherapy (CTx), radiotherapy (RT), best supportive care (BSC) were searched from Medline, Embase, Cochrane library, Scopus and Web of Science from 1976 to April 30, 2016. To visualize the mapping of evidence, we established a web-based mapping tool ( http://plotting-e-map.com ) and used it. In the treatment options with selected study types, subgroup meta-analyses were conducted using overall survival as a primary endpoint. Results: Among detected 12,040 studies, a total of 162 studies were included. In locally recurrent PC, overall 126 studies (39 of ReOP, 40 of CTx, 37 of RT, and 10 of BSC) were included. Median overall survival (OS) of each treatment option was 16.1 months (95% CI 4.9–22.1, I2 52%) for ReOP, 14.9 month (95% CI 7.5–18.9, I2 63%) for CTx, 13.8 months (95% CI 5.6–17.0, I2 59%) for RT. In metastatic recurred PC, overall 36 studies (10 of ReOP, 22 of CTx, no RT, 4 of BSC) were included. Median OS’s were 8.3 months (95% CI 3.6–11.2, I2 56%) for Re-OP, and 6.8 months (95% CI 4.1–9.5, I2 33%) for CTx. Conclusions: During recent 40 years, evidences showed that re-operation for highly selected patients with locally and metastatic recurrent PC could be a considerable therapeutic option. However, since the heterogeneity among the studies is relatively high, more prospective and comparative studies about re-operation with multimodality treatment are needed.


2020 ◽  
Vol 9 (1) ◽  
Author(s):  
Jisun So ◽  
Esther E. Avendano ◽  
Gowri Raman ◽  
Elizabeth J. Johnson

Abstract Background Recent systematic review of clinical trials concluded that there was no convincing evidence to suggest an association between potatoes and risk of cardio-metabolic diseases. Objective Summarize observational study data related to potato intake and cardio-metabolic health outcomes in adults using evidence mapping to assess the need for a future systematic review. Methods We searched MEDLINE®, Commonwealth Agricultural Bureau, and bibliographies for eligible observational studies published between 1946 and July 2020. Included studies evaluated potato intake in any form or as part of a dietary pattern with risk for cardio-metabolic diseases. Outcomes of interest included cardiovascular disease (CVD), cerebrovascular diseases, diabetes, hypertension, blood lipids, and body composition. Results Of 121 eligible studies, 51 reported two different methods to quantify potato intake (30 studies quantified intake as either grams or serving; 20 studies reported times per week; one reported both methods) and 70 reported potato as part of a dietary pattern and compared higher vs. lower intake, linear change, or difference in potato intake among cases and controls. Studies that quantified potato intake as either grams or serving reported the following outcomes: diabetes (8 studies); cerebrovascular stroke (6 studies); five studies each for CVD, systolic and diastolic blood pressure, and hypertension; three studies each for body mass index, body weight, CVD mortality; two studies for myocardial infarction; and one study each for blood glucose, HOMA-IR, and blood lipids. Higher potato intake was associated with an increased risk for blood pressure and body weight, and the results of all other outcomes observed no association. Potato consumption as part of dietary pattern studies reported a negative association between fried form of potato and all or most cardio-metabolic risk factors and diseases. Conclusion Evidence mapping found sufficient data on the association between potato intake and cardio-metabolic disease risk factors to warrant for a systematic review/meta-analysis of observational studies.


Sign in / Sign up

Export Citation Format

Share Document